Abbott India Limited , a prominent player in the pharmaceutical industry, has recently announced significant changes in its senior management, particularly within its Human Resources department.

New Leadership in Human Resources

Abbott India has appointed Ms. Vinutha Mufti as the new Director of Business Human Resources, effective December 16, 2025. This appointment comes as Mr. Rajan Kalantre, the current Director of Business Human Resources, is set to transition to another Abbott affiliate.

Key Details of the Transition

Mr. Kalantre will continue in his current role until December 15, 2025, ensuring a smooth transition of responsibilities.

Ms. Vinutha Mufti's Profile

Ms. Mufti brings over two decades of diverse HR experience to her new role at Abbott India. Her career highlights include:

• Joined Abbott in 2015 as Senior Manager - BHR for Nutrition
• Progressively held senior roles across Pharmaceuticals and Nutrition businesses
• Appointed as Head - BHR for Abbott's Primary Care business in 2020
• Became Associate Director - BHR for Nutrition in 2022
• Most recently served as Director - BHR for the Specialty Care business in 2023

Prior to joining Abbott, Ms. Mufti spent a decade at IBM in HRBP and Talent Management roles. Her educational background includes a B.E. in Electronics and Telecommunication from PCCE-Goa and a PGDBM in Management from Goa Institute of Management.

Impact and Expectations

This leadership change is expected to bring fresh perspectives to Abbott India's HR strategies. Ms. Mufti's extensive experience within Abbott and her prior role at IBM position her well to drive key initiatives in managerial effectiveness, diversity, equity, and inclusion (DEI), and talent management.

Abbott India's decision to promote from within for this crucial role demonstrates the company's commitment to nurturing internal talent and ensuring continuity in its HR leadership.

As the pharmaceutical industry continues to evolve, strong HR leadership will be vital in attracting, retaining, and developing top talent. Ms. Mufti's appointment is likely to play a significant role in shaping Abbott India's human resource strategies in the coming years.

Abbott India Announces Leadership Change

Abbott India Limited, a prominent player in the pharmaceutical sector, has announced a significant change in its top leadership. The company's Board of Directors has approved the appointment of Ambati Venu as the new Managing Director, effective from May 15, 2023.

Key Details of the Appointment

• New Managing Director: Ambati Venu
• Effective Date: May 15, 2023
• Tenure: 5 years (subject to regulatory approvals)

About Ambati Venu

Ambati Venu brings a wealth of experience to his new role at Abbott India. His professional background includes:

• Over 29 years of diverse experience in the pharmaceutical industry
• Previous role as Managing Director of Abbott India from September 2016 to February 2020
• Most recent position as Group Vice President and Head of Established Pharmaceuticals Division for Abbott's global operations

Corporate Governance Implications

This appointment aligns with the requirements outlined in Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's prompt disclosure of this significant change in leadership demonstrates its commitment to transparency and compliance with regulatory standards.

Conclusion

The appointment of Ambati Venu as Managing Director marks a new chapter for Abbott India Limited. With his extensive industry experience and previous tenure with the company, stakeholders will be observing how his leadership shapes Abbott India's future in the pharmaceutical landscape.